NephroGenex, Inc.
Pharmaceutical company · Jamison, Pennsylvania, United States
NephroGenex, Inc. is a pharmaceutical company headquartered in Jamison, Pennsylvania, United States. It has reported private securities offerings to the US SEC, most recently $5.5 million sold in a notice filed in 2015.
Profile compiled from public records. Is this your company? Request a correction or update
NephroGenex at a glance
Typepharmaceutical company
HeadquartersJamison, Pennsylvania, United States
SEC industryPharmaceutical Preparations
SEC CIK1338095
What does NephroGenex do?
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $5.5 million sold (2015).
Frequently asked questions about NephroGenex
Where is NephroGenex headquartered?
NephroGenex, Inc. is headquartered in Jamison, Pennsylvania, United States.
What does NephroGenex do?
NephroGenex, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Similar companies
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
- Cellectar Biosciences, Inc.Florham Park, New Jersey, United States
- Marker Therapeutics, Inc.Houston, Texas, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences